Literature DB >> 10960400

Recurring brachial plexus neuropathy in a diabetic patient after shoulder surgery and continuous interscalene block.

T T Horlocker1, S W O'Driscoll, R P Dinapoli.   

Abstract

IMPLICATIONS: The performance of regional blockade on a patient with a preexisting neurologic condition or a history of neurologic complications after regional anesthesia is controversial. We present a case of recurring brachial plexus neuropathy in a diabetic patient after two shoulder procedures performed 4 mo apart. In both cases, the patient underwent intensive physical therapy with continuous postoperative interscalene analgesia.

Entities:  

Mesh:

Year:  2000        PMID: 10960400     DOI: 10.1097/00000539-200009000-00035

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  5 in total

Review 1.  [Regional anesthesia and neurological diseases].

Authors:  B Sinner; B M Graf
Journal:  Anaesthesist       Date:  2010-09       Impact factor: 1.041

2.  Complications and controversies of regional anaesthesia: a review.

Authors:  Anil Agarwal; Kamal Kishore
Journal:  Indian J Anaesth       Date:  2009-10

3.  Perineural administration of dexmedetomidine in combination with bupivacaine enhances sensory and motor blockade in sciatic nerve block without inducing neurotoxicity in rat.

Authors:  Chad M Brummett; Mary A Norat; John M Palmisano; Ralph Lydic
Journal:  Anesthesiology       Date:  2008-09       Impact factor: 7.892

4.  Comparison of analgesic efficacy between single interscalene block combined with a continuous intra-bursal infusion of ropivacaine and continuous interscalene block after arthroscopic rotator cuff repair.

Authors:  Joo Han Oh; Ka-Young Rhee; Sae Hoon Kim; Pyung-Bok Lee; Joon-Woo Lee; Seok Jae Lee
Journal:  Clin Orthop Surg       Date:  2009-02-06

5.  Which is your choice for prolonging the analgesic duration of single-shot interscalene brachial blocks for arthroscopic shoulder surgery? intravenous dexamethasone 5 mg vs. perineural dexamethasone 5 mg randomized, controlled, clinical trial.

Authors:  Eun Hee Chun; Youn Jin Kim; Jae Hee Woo
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.